 Monica Federico
Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 15 | 2022 | 2158 | 2.380 |
Why?
| | Social Determinants of Health | 2 | 2020 | 129 | 0.780 |
Why?
| | Virus Diseases | 1 | 2021 | 198 | 0.680 |
Why?
| | Anti-Asthmatic Agents | 2 | 2020 | 343 | 0.660 |
Why?
| | Medication Adherence | 2 | 2020 | 556 | 0.610 |
Why?
| | Patient Discharge | 1 | 2022 | 796 | 0.540 |
Why?
| | Dexamethasone | 2 | 2019 | 320 | 0.370 |
Why?
| | Poverty | 3 | 2019 | 444 | 0.330 |
Why?
| | Health Status Disparities | 2 | 2020 | 209 | 0.300 |
Why?
| | Anti-Ulcer Agents | 1 | 2005 | 16 | 0.260 |
Why?
| | Urban Health | 1 | 2003 | 78 | 0.230 |
Why?
| | Child | 11 | 2021 | 19129 | 0.210 |
Why?
| | Prednisone | 2 | 2019 | 235 | 0.200 |
Why?
| | Lymphocyte Activation | 1 | 2005 | 1067 | 0.190 |
Why?
| | Residence Characteristics | 2 | 2020 | 299 | 0.190 |
Why?
| | Phenotype | 2 | 2021 | 3003 | 0.190 |
Why?
| | Frustration | 1 | 2020 | 6 | 0.190 |
Why?
| | Aftercare | 1 | 2022 | 194 | 0.180 |
Why?
| | Respiratory Sounds | 2 | 2021 | 119 | 0.180 |
Why?
| | Pneumonia | 1 | 2005 | 592 | 0.170 |
Why?
| | Nebulizers and Vaporizers | 2 | 2017 | 82 | 0.170 |
Why?
| | Family Relations | 1 | 2020 | 85 | 0.170 |
Why?
| | Humans | 17 | 2022 | 118972 | 0.170 |
Why?
| | Housing | 1 | 2020 | 123 | 0.170 |
Why?
| | Biomarkers | 2 | 2021 | 3588 | 0.160 |
Why?
| | Environment | 2 | 2019 | 346 | 0.160 |
Why?
| | Respiratory Tract Infections | 1 | 2021 | 331 | 0.150 |
Why?
| | Allergens | 1 | 2021 | 424 | 0.150 |
Why?
| | T-Lymphocytes | 1 | 2005 | 1774 | 0.150 |
Why?
| | Patient Education as Topic | 1 | 2022 | 699 | 0.150 |
Why?
| | Positive-Pressure Respiration | 1 | 2017 | 70 | 0.140 |
Why?
| | Urban Population | 1 | 2019 | 409 | 0.140 |
Why?
| | Cholinergic Antagonists | 1 | 2016 | 28 | 0.140 |
Why?
| | Airway Remodeling | 1 | 2016 | 57 | 0.140 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1129 | 0.140 |
Why?
| | Emergency Service, Hospital | 3 | 2022 | 1864 | 0.130 |
Why?
| | Hospitals, Pediatric | 1 | 2019 | 505 | 0.130 |
Why?
| | Albuterol | 2 | 2017 | 104 | 0.130 |
Why?
| | Glucocorticoids | 2 | 2017 | 545 | 0.130 |
Why?
| | Drug Monitoring | 1 | 2016 | 187 | 0.130 |
Why?
| | Prevalence | 2 | 2016 | 2326 | 0.130 |
Why?
| | Practice Guidelines as Topic | 2 | 2016 | 1440 | 0.120 |
Why?
| | Healthcare Disparities | 1 | 2019 | 496 | 0.120 |
Why?
| | Risk Factors | 4 | 2019 | 9000 | 0.120 |
Why?
| | Bronchodilator Agents | 2 | 2017 | 253 | 0.120 |
Why?
| | Severity of Illness Index | 4 | 2019 | 2674 | 0.100 |
Why?
| | Smoking | 1 | 2019 | 1487 | 0.100 |
Why?
| | Practice Patterns, Physicians' | 1 | 2019 | 1200 | 0.090 |
Why?
| | Argyria | 1 | 2007 | 4 | 0.080 |
Why?
| | Silver | 1 | 2007 | 27 | 0.080 |
Why?
| | Skin Pigmentation | 1 | 2007 | 43 | 0.080 |
Why?
| | Bronchial Provocation Tests | 1 | 2006 | 54 | 0.070 |
Why?
| | Bronchial Hyperreactivity | 1 | 2006 | 95 | 0.070 |
Why?
| | Spirometry | 1 | 2006 | 263 | 0.070 |
Why?
| | Patient-Centered Care | 1 | 2011 | 497 | 0.070 |
Why?
| | Health Services Accessibility | 2 | 2019 | 781 | 0.070 |
Why?
| | Inhibitory Concentration 50 | 1 | 2005 | 81 | 0.060 |
Why?
| | Histamine H2 Antagonists | 1 | 2005 | 31 | 0.060 |
Why?
| | Respiratory Hypersensitivity | 1 | 2005 | 65 | 0.060 |
Why?
| | Proton Pump Inhibitors | 1 | 2005 | 98 | 0.060 |
Why?
| | Overweight | 1 | 2008 | 502 | 0.060 |
Why?
| | Community-Acquired Infections | 1 | 2005 | 143 | 0.060 |
Why?
| | Reference Values | 1 | 2005 | 774 | 0.060 |
Why?
| | Forced Expiratory Volume | 1 | 2005 | 520 | 0.060 |
Why?
| | Interleukins | 1 | 2005 | 242 | 0.060 |
Why?
| | In Vitro Techniques | 1 | 2005 | 1094 | 0.060 |
Why?
| | Immune Tolerance | 1 | 2005 | 334 | 0.060 |
Why?
| | Child, Preschool | 3 | 2021 | 9491 | 0.050 |
Why?
| | Hospitalization | 2 | 2021 | 1785 | 0.050 |
Why?
| | Adolescent | 4 | 2011 | 18480 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 1945 | 0.050 |
Why?
| | Male | 7 | 2019 | 57801 | 0.050 |
Why?
| | Pulmonologists | 1 | 2019 | 15 | 0.040 |
Why?
| | Gene Expression | 1 | 2005 | 1489 | 0.040 |
Why?
| | Symptom Flare Up | 1 | 2019 | 41 | 0.040 |
Why?
| | Environmental Exposure | 1 | 2003 | 405 | 0.040 |
Why?
| | Drug Substitution | 1 | 2019 | 46 | 0.040 |
Why?
| | Quality of Health Care | 1 | 2003 | 586 | 0.040 |
Why?
| | Cystic Fibrosis | 1 | 2007 | 964 | 0.040 |
Why?
| | Health Resources | 1 | 2019 | 132 | 0.040 |
Why?
| | Ipratropium | 1 | 2017 | 5 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2005 | 2657 | 0.040 |
Why?
| | Drug Administration Schedule | 1 | 2019 | 736 | 0.040 |
Why?
| | Consensus | 1 | 2019 | 534 | 0.040 |
Why?
| | Single-Blind Method | 1 | 2017 | 269 | 0.040 |
Why?
| | Hospitalists | 1 | 2019 | 173 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2005 | 2275 | 0.030 |
Why?
| | Female | 5 | 2017 | 61564 | 0.030 |
Why?
| | Self Report | 1 | 2019 | 699 | 0.030 |
Why?
| | Disease Management | 1 | 2019 | 571 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1166 | 0.030 |
Why?
| | Clinical Competence | 1 | 2019 | 951 | 0.030 |
Why?
| | Age Factors | 1 | 2019 | 2995 | 0.030 |
Why?
| | United States | 2 | 2008 | 12555 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 1185 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 5255 | 0.020 |
Why?
| | Hospitals, Teaching | 1 | 2011 | 104 | 0.020 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2011 | 79 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2021 | 12978 | 0.020 |
Why?
| | Drug Utilization | 1 | 2011 | 169 | 0.020 |
Why?
| | Infant | 1 | 2021 | 8293 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 983 | 0.020 |
Why?
| | Colloids | 1 | 2007 | 60 | 0.020 |
Why?
| | Complementary Therapies | 1 | 2007 | 71 | 0.020 |
Why?
| | Adult | 2 | 2008 | 31512 | 0.020 |
Why?
| | Aged | 1 | 2005 | 19657 | 0.020 |
Why?
| | Prospective Studies | 1 | 2017 | 6471 | 0.020 |
Why?
| | Middle Aged | 1 | 2005 | 27617 | 0.020 |
Why?
| | Quality Improvement | 1 | 2011 | 963 | 0.010 |
Why?
| | Comorbidity | 1 | 2008 | 1527 | 0.010 |
Why?
| | Colorado | 1 | 2011 | 4196 | 0.010 |
Why?
| | Case-Control Studies | 1 | 2008 | 3171 | 0.010 |
Why?
| | Body Mass Index | 1 | 2008 | 2092 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 4708 | 0.010 |
Why?
|
|
Federico's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|